American College of Clinical Pharmacy
      Search      Cart
         

Weighting on the World to Change: Updates on the Management of Overweight and Obesity


Format to Purchase:
Member Price:
$24.94
Nonmember Price:
$49.95

Emerging data on the clinical benefits of incretin-based pharmacotherapy for the management of persons with overweight or obesity has brought glucagon-like peptide-1 (GLP-1) and GLP-1/glucose-dependent insulinotropic polypeptide (GIP) agonists to the forefront of patient-provider conversations, popular media, and policy discussions. Anticipated multi-society guidelines for the management of overweight and obesity and an increasingly robust pipeline of incretin-based and other peptide therapies will have a significant impact on the future of cardiometabolic care. Evidence supporting new agents for weight management, the most recent practice guidelines related to this chronic condition, and national policy updates related to coverage for these agents will be reviewed during this program. In addition, this session will allow the speakers to share their practice experience working with this patient population and allow for a discussion of the benefits and challenges of a pharmacist-led service for people who are overweight or obese.

Release Date: November 12, 2025
ACPE Deadline: October 19, 2028

Publication Year: 2025
Format: Recorded Lecture

Technical Requirements:

To access this on-demand content, you will need broadband Internet access, an updated Internet browser, and speakers or headphones for audio.

Contents

Weighting on the World to Change: Updates on the Management of Overweight and Obesity

  • The Low-Down on Scaling Down: New Therapies for the Management of Persons with Overweight or Obesity
  • A Long A-Weighted Update: A Review of New Clinical Practice Guidelines for the Management of Persons with Overweight or Obesity
  • Worth the Weight: Policy Updates on the Coverage of Medications for Weight Management and Impact on Access

Weighting on the World to Change: Updates on the Management of Overweight and Obesity

Faculty

Amy K. Leung, Pharm.D., BCPS
Clinical Pharmacist Practitioner (CPP)
Phoenix VA Health Care System
Phoenix, AZ
Abby Lennon, Pharm.D., BCACP, CDCES
Clinical Pharmacy Specialist - Bariatrics & Endocrinology
Inova
Fairfax, VA
Lindsay A. Courtney, Pharm.D., BCACP, BCPS
Assistant Professor
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Amarillo, TX

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience: Pharmacists

Contents

Weighting on the World to Change: Updates on the Management of Overweight and Obesity

Activity Number: 217-0000-25-124-H01-P
Contact Hour(s): 1.50
Activity Type: Knowledge Based
Learning Objectives
  1. Discuss the mechanisms of action of newer incretin- and peptide-based therapies developed for the management of persons with overweight or obesity.
  2. Review evidence supporting the use of newer incretin-based and peptide therapies in the management of persons with overweight or obesity.
  3. Describe recent updates in clinical practice guidelines for the management of persons with overweight or obesity.
  4. Identify changes to policies related to the coverage of pharmacotherapy for weight management and its impact on medication access.
  5. Explain the impact of new evidence, practice recommendations, and policy updates to the management of overweight and obesity through a patient case.

Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.